Purchase Order 75N95023P00570
Award Date
8/17/23
Potential Completion Date
9/15/23
Potential Value
$13K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Promega Corporation
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Madison, WI 53711, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Promega Corporation for 100,000 units of the ADP-GLO Kinase Assay (Promega Product #V9103) with a potential value of $17,990.25. The contract has a performance period running through September 30, 2024. Promega is a global life sciences company that provides DNA analysis equipment, reagents, assays, and...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,294.20 firm fixed price purchase order to Promega Corporation for CASPASE-GLO(R) 3/7 ASSAY, 100ML. The contract has a completion date of September 8, 2023 and was awarded on August 18, 2023. This order is not associated with a set-aside program. Promega Corporation is a global life sciences company that provides various biological research and diagnostic...
The National Institutes of Health National Center for Advancing Translational Sciences awarded a firm-fixed price purchase order to Promega Corporation for $24,640.20 to supply 18 units of Promega CellTiter-Glo(R) One Solution Assay 500 ml, a one-step, homogenous reagent used to detect ATP levels without additional reagents. The purchase order was awarded non-competitively on March 1, 2024 and delivery is required by March 14, 2024 to support various Early Translation Branch projects at the...
This contract was awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Promega Corporation, a for-profit manufacturer of laboratory equipment, reagents, and consumables. The $113,836.25 firm fixed-price purchase order is for the delivery of Promega's Caspase-Glo 3/7 Assay and CellTiter-Glo One Solution Assay, which are used in cell-based assays to test the apoptosis detection and cytotoxicity of siRNA libraries. The contract does not utilize a set-aside...
This firm-fixed-price purchase order was awarded to Promega Corporation, a global life sciences company, by the National Center for Advancing Translational Sciences (NCATS) within the Department of Health and Human Services' National Institutes of Health. The $121,492.50 contract is for the procurement of detection assay systems with an August 2021 completion date. Promega has previously been awarded prime and subcontracts by various agencies including the NIH, CDC, DoD, and FBI to provide DNA...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a firm fixed price purchase order contract to Promega Corporation, a global life sciences company, for the provision of reagent kits and assays. The contract has a potential value of $22,784.00 and a completion date of July 21, 2020. Promega has previously provided DNA analysis equipment, reagents, assays, and related laboratory supplies to federal agencies...
The National Center for Advancing Translational Sciences, a civilian agency within the U.S. Department of Health and Human Services, awarded a Firm Fixed Price Purchase Order contract to Promega Corporation, a for-profit manufacturer of biological research and diagnostic products. The $66,970.35 contract is for the delivery of Promega's proprietary laboratory equipment, reagents, and consumables to support the agency's biomedical research and testing programs. This award is under a $10 million...
This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Promega Corporation, a global life sciences company based in Madison, Wisconsin. The contract, valued at $79,736.40, is for the delivery of a LUCIFERASE 1000 ASSAY (AMBIS #1676428) product from Promega. This award does not utilize any set-aside designation. Promega is a major supplier of specialized laboratory equipment,...
This federal contract award, valued at $3,451.95, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to Promega Corporation, a global life sciences company headquartered in Madison, Wisconsin. The award is for the purchase of CellTiter-Glo Luminescent Cell Viability Assay reagents, which are used for biological research, molecular diagnostics, and forensic analysis. Promega has supplied a range of specialized laboratory...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Promega Corporation, a large for-profit manufacturer of laboratory equipment and reagents. The contract has a ceiling value of $11,469.15 and covers the purchase of various Promega reagents, including catalog numbers MG1010 (x2), G9242, E8120, and MG1001, with shipping and handling included. The contract has a performance period through July 31, 2025 and...